Pharmacotherapy Impact on Cocaine and Alcohol-derived Reinforcement.
Pharmacotherapy Impact on Cocaine and Alcohol-derived Reinforcement.
批准号:
8323963
负责人:
Jennifer Grace Plebani
金额:
$13.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2014-08-31
关键词:
AcuteAddressAdverse effectsAlcoholsAwardBehavioralChantixChronicClinicalClinical TrialsCocaineCocaine DependenceComplementCrossover DesignDataData AnalysesDependenceDevelopmentDoctor of PhilosophyDoseFoundationsFundingFutureGoalsGrantHealth ExpendituresHumanHuman VolunteersHypertensionIndividualInstructionKnowledgeLaboratoriesLaboratory StudyMeasurementMentorsMentorshipOutpatientsParticipantPennsylvaniaPharmaceutical PreparationsPharmacotherapyPhysiologicalPlacebosPostdoctoral FellowPrincipal InvestigatorPsychological reinforcementPublic HealthRandomizedRelapseRelative (related person)ResearchResearch DesignResearch PersonnelResearch TrainingSafetySecureSelf AdministrationSocietiesSocioeconomic StatusStructureSubstance AddictionTestingTrainingUniversitiesaddictionbasebehavioral pharmacologycholinergiccocaine usecosteffective therapyexperiencehuman subject protectionhuperzine Ainterestmeetingsprogramsrandomized trialvarenicline
中文摘要
可卡因使用、滥用和依赖是一个公共卫生问题,
每年数千亿美元的医疗保健支出。可卡因使用的复吸率是
高,迫切需要开发有效的可卡因依赖疗法。因此,这
研究对于进一步了解可卡因依赖性和开发有效的
新疗法本申请的目的是为Jennifer G.普莱巴尼,
哲学博士、宾夕法尼亚大学成瘾研究中心(CSA)的博士后研究员,
成为一名在可卡因依赖药物治疗方面具有专业知识的独立调查员,
并专注于人类实验室研究。这个建议是建立在她对人类的现有知识的基础上的。
物质依赖的行为实验室研究,以及物质依赖的有限临床经验
通过精心设计的培训和研究计划,包括教学培训,
课程和体验式实验室培训。在这个奖项的过程中。普列巴尼博士会建造
她目前接受海伦·佩蒂纳蒂博士的博士后指导,
依赖她将接受一组具有药物治疗经验的研究人员的指导
可卡因(奥布莱恩和Kampman)、人体实验室研究(Oslin)、可卡因自我给药
研究(哈特)、药物强化研究(沃尔什)以及统计分析和研究设计
受试者内交叉设计(Lynch)。拟议的研究和培训将侧重于
调查可卡因依赖的决定因素和后果,
急性剂量可卡因对人类志愿者的生理、行为和主观影响
实验室,并通过检查药物治疗对上述作用的影响,
可卡因这两项研究将研究可卡因衍生的强化下,为期一周的亚,
长期伐尼克兰(Chantix)给药,和在安慰剂条件下(研究1),和在为期一周的
亚慢性石杉碱甲给药和安慰剂条件下(研究2)。每一项研究都是一个内在的-
受试者交叉设计该KOI奖将使Plebani博士能够建立所需的专业知识,
为未来可卡因的人类行为药理学实验室研究提供投资回报率资金
依赖
相关性(参见说明):
可卡因的使用、滥用和依赖是一个公共卫生问题,
每年数千亿美元的医疗保健支出。到目前为止,还没有有效的
可卡因依赖的药物治疗已经发现。这个项目的目标是检查
胆碱能药物治疗可卡因依赖的潜在疗效。
英文摘要
Cocaine use, abuse and dependence is a public health problem that Is directly responsible for
hundreds of billions of dollars in health care expenditures per year. Relapse rates to cocaine use are
high, creating a pressing need to develop effective therapies for cocaine dependence. As such, this
research is important for furthering understanding of cocaine dependence, and for developing effective
new treatments. The purpose of this application is to lay the foundation for Dr. Jennifer G. Plebani,
Ph.D., a Postdoctoral Fellow at the University of Pennsylvania Center for Studies of Addiction (CSA),
to become an independent investigator with expertise in pharmacotherapies for cocaine dependence,
and a focus on human laboratory studies. The proposal builds on her existing knowledge of human
behavioral laboratory studies for substance dependence, and limited clinical experience in substance
dependence through a carefully structured training and research program involving didactic training,
coursework, and experiential laboratory training. During the course of this award. Dr. Plebani will build
on the postdoctoral mentorship she Is currently receiving from Dr. Helen Pettinati in treating cocaine
dependence. She will be mentored by a team of investigators with experience in pharmacotherapies
for cocaine (O'Brien and Kampman), human laboratory studies (Oslin), cocaine self-administration
studies (Hart), studies of drug-derived reinforcement (Walsh), and statistical analysis and study design
for within-subjects cross-over designs (Lynch). The proposed research and training will focus on
investigating the determinants and consequences of cocaine dependence via measurement of
physiological, behavioral and subjective effects of acute doses of cocaine in human volunteers in the
laboratory, and through examination of the effects of pharmacotherapies on the above effects of
cocaine. The two studies proposed will examine cocaine-derived reinforcement under week-long sub-
chronic varenicline (Chantix") dosing, and under placebo conditions (Study 1), and under week-long
sub-chronic Huperzine A dosing, and under placebo conditions (Study 2). Each study is a within-
subjects crossover design. This KOI award will allow Dr. Plebani to establish the expertise required to
secure ROI funding for future human behavioral pharmacology laboratory studies of cocaine
dependence.
RELEVANCE (See instructions):
Cocaine use, abuse and dependence represent a public health problem that Is directly responsible for
hundreds of billions of dollars in health care expenditures per year. As yet, no efficacious
pharmacotherapies for cocaine dependence have been found. The goal of this project is to examine
the potential efficacy of cholinergic medications in treating cocaine dependence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Varenicline for the treatment of cocaine dependence: Phase II
-
批准号:8469851
-
项目类别:
-
资助金额:$57.72万
-
财政年份:2012
-
负责人:Jennifer Grace Plebani
-
依托单位:
Varenicline for the treatment of cocaine dependence: Phase II
-
批准号:8724087
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:Jennifer Grace Plebani
-
依托单位:
Varenicline for the treatment of cocaine dependence: Phase II
-
批准号:8297128
-
项目类别:
-
资助金额:$60.24万
-
财政年份:2012
-
负责人:Jennifer Grace Plebani
-
依托单位:
Varenicline for the treatment of cocaine dependence: Phase II
-
批准号:8660681
-
项目类别:
-
资助金额:$60.12万
-
财政年份:2012
-
负责人:Jennifer Grace Plebani
-
依托单位:
Pharmacotherapy Impact on Cocaine and Alcohol-derived Reinforcement.
-
批准号:7937706
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2009
-
负责人:Jennifer Grace Plebani
-
依托单位:
Pharmacotherapy Impact on Cocaine and Alcohol-derived Reinforcement.
-
批准号:7741096
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2009
-
负责人:Jennifer Grace Plebani
-
依托单位:
Pharmacotherapy Impact on Cocaine and Alcohol-derived Reinforcement.
-
批准号:8135049
-
项目类别:
-
资助金额:$13.07万
-
财政年份:2009
-
负责人:Jennifer Grace Plebani
-
依托单位:
海外基金